Nisa Investment Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Nisa Investment Advisors's FLNA Position: Q1 2026 in Review
Nisa Investment Advisors held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 362 shares worth $612. The position accounts for ﹤0.01% of the portfolio, ranked #2833.
Nisa Investment Advisors first reported a position in FLNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $33K in Q2 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Nisa Investment Advisors held 362 shares of Filana Therapeutics worth $612 as of Q1 2026.
- Nisa Investment Advisors left its Filana Therapeutics share count unchanged in Q1 2026.
- Filana Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2833 holding.
- Nisa Investment Advisors first reported a position in Filana Therapeutics in Q4 2020 and has held it in 22 quarters since.
- Nisa Investment Advisors's Filana Therapeutics position peaked at $33K in Q2 2022.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.